Lindahl advises Senzime AB on a directed new share issue of SEK 100 million
Lindahl has advised Senzime AB (publ) in connection with a directed new share issue that will provide the company with SEK 100 million before transaction costs.
The subscription price was determined through an accelerated bookbuilding process, with Carnegie Investment Bank acting as financial adviser.
About Senzime
Senzime AB is a company listed on Nasdaq Stockholm that develops and markets CE and FDA approved monitoring systems for patients undergoing anaesthesia.
Lindahl's team consisted of Mattias Prage, Andreas Mellberg and Michaela Larsson.
Do you want to know more? Contact:
Mattias Prage
Partner | AdvokatMichaela Larsson
Associate | AdvokatAndreas Mellberg
Counsel | AdvokatCarousel items
-
News articles
4/1/2026
Insights from Oxford: climate transition is business-critical
When leading experts gathered in Oxford for this year's Climate Policy Monitor symposium, one thing was clear: climate is no longer purely a regulatory issue – it is business-critical.
-
Knowledge
3/30/2026
How to deal with bankruptcy during legal proceedings
What happens to ongoing legal proceedings if the opposing party goes bankrupt? We explain the estate's right to take over the claim and the risks involved.
-
Cases and transactions
3/23/2026
Lindahl advises Seafire on the acquisition of Splendor Plant AB
Lindahl has acted as legal adviser to Seafire in connection with the acquisition of all shares in Splendor Plant AB, the Nordic region's leading wholesale plant nursery, and in negotiations regarding an expanded financing agreement with its existi...
-
Portraits
1/20/2026
How I use AI in my daily work as a lawyer
AI is no longer the future – it is everyday reality. Johanna Karlsson, lawyer and senior associate at Lindahl, talks about how AI tools such as Legora have become a natural part of her workflow.
-
Read more news and insights?
